| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid binding | 1.77e-07 | 28 | 36 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 4.48e-07 | 35 | 36 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | retinoid binding | 1.64e-06 | 48 | 36 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 1.78e-06 | 49 | 36 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | transcription factor binding | 5.54e-06 | 753 | 36 | 9 | GO:0008134 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 5.92e-06 | 66 | 36 | 4 | GO:0005080 | |
| GeneOntologyMolecularFunction | fatty acid binding | 7.07e-06 | 69 | 36 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 4.02e-05 | 107 | 36 | 4 | GO:0033293 | |
| GeneOntologyMolecularFunction | chromatin binding | 4.08e-05 | 739 | 36 | 8 | GO:0003682 | |
| GeneOntologyMolecularFunction | ferroxidase activity | 4.72e-05 | 6 | 36 | 2 | GO:0004322 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions, oxygen as acceptor | 4.72e-05 | 6 | 36 | 2 | GO:0016724 | |
| GeneOntologyMolecularFunction | steroid binding | 9.39e-05 | 133 | 36 | 4 | GO:0005496 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 1.61e-04 | 153 | 36 | 4 | GO:0008194 | |
| GeneOntologyMolecularFunction | copper ion binding | 3.73e-04 | 78 | 36 | 3 | GO:0005507 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 4.59e-04 | 562 | 36 | 6 | GO:0003712 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions | 4.75e-04 | 18 | 36 | 2 | GO:0016722 | |
| GeneOntologyMolecularFunction | SMAD binding | 4.97e-04 | 86 | 36 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 5.48e-04 | 211 | 36 | 4 | GO:0016758 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 8.73e-04 | 239 | 36 | 4 | GO:0031406 | |
| GeneOntologyMolecularFunction | organic acid binding | 1.09e-03 | 254 | 36 | 4 | GO:0043177 | |
| GeneOntologyMolecularFunction | lipid binding | 1.68e-03 | 988 | 36 | 7 | GO:0008289 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 1.74e-03 | 288 | 36 | 4 | GO:0016757 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 2.02e-03 | 37 | 36 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 2.03e-03 | 140 | 36 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.09e-03 | 303 | 36 | 4 | GO:0003713 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 3.10e-03 | 815 | 36 | 6 | GO:0042803 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 3.69e-03 | 582 | 36 | 5 | GO:0140297 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 3.81e-03 | 51 | 36 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 4.15e-03 | 1160 | 36 | 7 | GO:0030674 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 4.42e-03 | 55 | 36 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 4.60e-03 | 187 | 36 | 3 | GO:0016922 | |
| GeneOntologyMolecularFunction | protein dimerization activity | 5.11e-03 | 1205 | 36 | 7 | GO:0046983 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 5.24e-03 | 60 | 36 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 5.41e-03 | 61 | 36 | 2 | GO:0030374 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 5.53e-03 | 398 | 36 | 4 | GO:0046982 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 6.51e-03 | 417 | 36 | 4 | GO:0061629 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 7.54e-03 | 435 | 36 | 4 | GO:0004857 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 8.71e-03 | 78 | 36 | 2 | GO:0008080 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 9.61e-03 | 1356 | 36 | 7 | GO:0060090 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 9.81e-03 | 83 | 36 | 2 | GO:1990841 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 3.90e-11 | 5 | 36 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 1.17e-10 | 6 | 36 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 1.17e-10 | 6 | 36 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 1.17e-10 | 6 | 36 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 1.63e-09 | 10 | 36 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 1.63e-09 | 10 | 36 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 5.52e-09 | 13 | 36 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 4.58e-08 | 21 | 36 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 4.58e-08 | 21 | 36 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 4.87e-08 | 5 | 36 | 3 | GO:0052696 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 1.08e-07 | 67 | 36 | 5 | GO:0019748 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.14e-07 | 26 | 36 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.14e-07 | 26 | 36 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 3.49e-07 | 34 | 36 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 5.95e-07 | 94 | 36 | 5 | GO:0042440 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 1.06e-06 | 12 | 36 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 1.99e-06 | 52 | 36 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 3.15e-06 | 237 | 36 | 6 | GO:0019827 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 3.56e-06 | 242 | 36 | 6 | GO:0098727 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 1.57e-05 | 87 | 36 | 4 | GO:0033143 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 1.72e-05 | 89 | 36 | 4 | GO:0001523 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 2.13e-05 | 94 | 36 | 4 | GO:0016101 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 3.29e-05 | 105 | 36 | 4 | GO:0006721 | |
| GeneOntologyBiologicalProcess | gland development | 4.31e-05 | 558 | 36 | 7 | GO:0048732 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 4.33e-05 | 376 | 36 | 6 | GO:0008202 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 4.61e-05 | 40 | 36 | 3 | GO:0042573 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 4.97e-05 | 41 | 36 | 3 | GO:0035909 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 6.21e-05 | 244 | 36 | 5 | GO:0009755 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 9.04e-05 | 136 | 36 | 4 | GO:0030518 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 1.04e-04 | 141 | 36 | 4 | GO:0006805 | |
| GeneOntologyBiologicalProcess | ventricular compact myocardium morphogenesis | 1.06e-04 | 9 | 36 | 2 | GO:0003223 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 1.13e-04 | 144 | 36 | 4 | GO:0006720 | |
| GeneOntologyBiologicalProcess | estrogen receptor signaling pathway | 1.34e-04 | 57 | 36 | 3 | GO:0030520 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 1.50e-04 | 155 | 36 | 4 | GO:0043401 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 1.54e-04 | 684 | 36 | 7 | GO:0010817 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 1.61e-04 | 929 | 36 | 8 | GO:0009792 | |
| GeneOntologyBiologicalProcess | aorta development | 3.66e-04 | 80 | 36 | 3 | GO:0035904 | |
| GeneOntologyBiologicalProcess | ventricular trabecula myocardium morphogenesis | 3.96e-04 | 17 | 36 | 2 | GO:0003222 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 4.11e-04 | 202 | 36 | 4 | GO:0141193 | |
| GeneOntologyBiologicalProcess | liver development | 4.11e-04 | 202 | 36 | 4 | GO:0001889 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 4.35e-04 | 205 | 36 | 4 | GO:0061008 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | 4.99e-04 | 382 | 36 | 5 | GO:0016042 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 4.99e-04 | 1390 | 36 | 9 | GO:0045944 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 5.28e-04 | 596 | 36 | 6 | GO:0001701 | |
| GeneOntologyBiologicalProcess | glandular epithelial cell differentiation | 5.34e-04 | 91 | 36 | 3 | GO:0002067 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 5.51e-04 | 92 | 36 | 3 | GO:0048844 | |
| GeneOntologyBiologicalProcess | copper ion transport | 5.52e-04 | 20 | 36 | 2 | GO:0006825 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 5.87e-04 | 222 | 36 | 4 | GO:0071466 | |
| GeneOntologyBiologicalProcess | response to hepatocyte growth factor | 6.09e-04 | 21 | 36 | 2 | GO:0035728 | |
| GeneOntologyBiologicalProcess | cardiac right ventricle morphogenesis | 6.09e-04 | 21 | 36 | 2 | GO:0003215 | |
| GeneOntologyBiologicalProcess | embryo development | 6.36e-04 | 1437 | 36 | 9 | GO:0009790 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 7.34e-04 | 416 | 36 | 5 | GO:0030522 | |
| GeneOntologyBiologicalProcess | pancreas development | 7.45e-04 | 102 | 36 | 3 | GO:0031016 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 7.74e-04 | 239 | 36 | 4 | GO:0071383 | |
| GeneOntologyBiologicalProcess | lysosomal protein catabolic process | 7.98e-04 | 24 | 36 | 2 | GO:1905146 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 8.33e-04 | 1186 | 36 | 8 | GO:0007167 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 8.42e-04 | 906 | 36 | 7 | GO:0043009 | |
| GeneOntologyBiologicalProcess | developmental growth | 8.70e-04 | 911 | 36 | 7 | GO:0048589 | |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 9.71e-04 | 254 | 36 | 4 | GO:0000819 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 9.93e-04 | 445 | 36 | 5 | GO:0141091 | |
| GeneOntologyBiologicalProcess | protein catabolic process in the vacuole | 1.09e-03 | 28 | 36 | 2 | GO:0007039 | |
| GeneOntologyBiologicalProcess | chromosome segregation | 1.21e-03 | 465 | 36 | 5 | GO:0007059 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 1.32e-03 | 276 | 36 | 4 | GO:0007179 | |
| GeneOntologyBiologicalProcess | positive regulation of chromosome separation | 1.33e-03 | 31 | 36 | 2 | GO:1905820 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.42e-03 | 482 | 36 | 5 | GO:0007178 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | 1.48e-03 | 727 | 36 | 6 | GO:0032870 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 1.50e-03 | 286 | 36 | 4 | GO:0042445 | |
| GeneOntologyBiologicalProcess | artery development | 1.60e-03 | 133 | 36 | 3 | GO:0060840 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 1.64e-03 | 134 | 36 | 3 | GO:0003279 | |
| GeneOntologyBiologicalProcess | regulation of intracellular estrogen receptor signaling pathway | 1.80e-03 | 36 | 36 | 2 | GO:0033146 | |
| GeneOntologyBiologicalProcess | heart trabecula morphogenesis | 2.00e-03 | 38 | 36 | 2 | GO:0061384 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 2.06e-03 | 525 | 36 | 5 | GO:0009410 | |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 2.17e-03 | 148 | 36 | 3 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 2.17e-03 | 148 | 36 | 3 | GO:0035113 | |
| GeneOntologyBiologicalProcess | negative regulation of intracellular steroid hormone receptor signaling pathway | 2.22e-03 | 40 | 36 | 2 | GO:0033144 | |
| GeneOntologyBiologicalProcess | type B pancreatic cell differentiation | 2.44e-03 | 42 | 36 | 2 | GO:0003309 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 2.70e-03 | 336 | 36 | 4 | GO:0071560 | |
| GeneOntologyBiologicalProcess | endocrine system development | 2.76e-03 | 161 | 36 | 3 | GO:0035270 | |
| GeneOntologyBiologicalProcess | columnar/cuboidal epithelial cell differentiation | 2.91e-03 | 164 | 36 | 3 | GO:0002065 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 2.91e-03 | 343 | 36 | 4 | GO:0071559 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 3.03e-03 | 347 | 36 | 4 | GO:0090092 | |
| HumanPheno | Frontal cortical atrophy | 6.67e-06 | 12 | 17 | 3 | HP:0006913 | |
| HumanPheno | Self-mutilation | 1.93e-05 | 51 | 17 | 4 | HP:0000742 | |
| HumanPheno | Trichiasis | 6.27e-05 | 4 | 17 | 2 | HP:0001128 | |
| MousePheno | decreased circulating luteinizing hormone level | 9.34e-06 | 21 | 28 | 3 | MP:0002773 | |
| MousePheno | decreased luteinizing hormone level | 3.43e-05 | 32 | 28 | 3 | MP:0005132 | |
| MousePheno | decreased red blood cell distribution width | 8.42e-05 | 43 | 28 | 3 | MP:0010068 | |
| Domain | UDPGT | 6.80e-08 | 21 | 36 | 4 | PS00375 | |
| Domain | UDPGT | 6.80e-08 | 21 | 36 | 4 | PF00201 | |
| Domain | UDP_glucos_trans | 6.80e-08 | 21 | 36 | 4 | IPR002213 | |
| Domain | MULTICOPPER_OXIDASE2 | 1.08e-05 | 3 | 36 | 2 | PS00080 | |
| Domain | Cu-oxidase | 1.08e-05 | 3 | 36 | 2 | PF00394 | |
| Domain | SSXT | 1.08e-05 | 3 | 36 | 2 | PF05030 | |
| Domain | SS18_fam | 1.08e-05 | 3 | 36 | 2 | IPR007726 | |
| Domain | Cu-oxidase | 1.08e-05 | 3 | 36 | 2 | IPR001117 | |
| Domain | Cu-oxidase_2 | 2.16e-05 | 4 | 36 | 2 | IPR011706 | |
| Domain | Cu-oxidase_2 | 2.16e-05 | 4 | 36 | 2 | PF07731 | |
| Domain | Cu-oxidase_3 | 3.60e-05 | 5 | 36 | 2 | IPR011707 | |
| Domain | Cu_oxidase_CS | 3.60e-05 | 5 | 36 | 2 | IPR033138 | |
| Domain | MULTICOPPER_OXIDASE1 | 3.60e-05 | 5 | 36 | 2 | PS00079 | |
| Domain | Cu-oxidase_3 | 3.60e-05 | 5 | 36 | 2 | PF07732 | |
| Domain | Cu_oxidase_Cu_BS | 5.39e-05 | 6 | 36 | 2 | IPR002355 | |
| Domain | - | 3.24e-04 | 14 | 36 | 2 | 2.60.40.420 | |
| Domain | Cupredoxin | 8.14e-04 | 22 | 36 | 2 | IPR008972 | |
| Domain | ARM-like | 1.75e-03 | 270 | 36 | 4 | IPR011989 | |
| Domain | HEAT | 3.85e-03 | 48 | 36 | 2 | PF02985 | |
| Domain | HEAT | 5.58e-03 | 58 | 36 | 2 | IPR000357 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 3.07e-08 | 41 | 32 | 5 | M7399 | |
| Pathway | WP_ESTROGEN_METABOLISM | 1.55e-07 | 22 | 32 | 4 | MM15888 | |
| Pathway | REACTOME_GLUCURONIDATION | 2.25e-07 | 24 | 32 | 4 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 2.67e-07 | 25 | 32 | 4 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 2.67e-07 | 25 | 32 | 4 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 2.67e-07 | 25 | 32 | 4 | M605 | |
| Pathway | WP_GLUCURONIDATION | 3.16e-07 | 26 | 32 | 4 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 4.31e-07 | 28 | 32 | 4 | M19580 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.70e-06 | 39 | 32 | 4 | MM15695 | |
| Pathway | REACTOME_ASPIRIN_ADME | 3.05e-06 | 45 | 32 | 4 | MM15694 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 3.80e-06 | 14 | 32 | 3 | M39328 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 3.92e-06 | 107 | 32 | 5 | MM14595 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 4.30e-06 | 109 | 32 | 5 | M18788 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 5.07e-06 | 51 | 32 | 4 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 5.48e-06 | 52 | 32 | 4 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 6.88e-06 | 55 | 32 | 4 | M14933 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.26e-05 | 64 | 32 | 4 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.80e-05 | 70 | 32 | 4 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 2.02e-05 | 72 | 32 | 4 | M9257 | |
| Pathway | REACTOME_DRUG_ADME | 1.03e-04 | 109 | 32 | 4 | M45012 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 1.15e-04 | 42 | 32 | 3 | M48237 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 1.15e-04 | 42 | 32 | 3 | M17541 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.24e-04 | 219 | 32 | 5 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.26e-04 | 220 | 32 | 5 | M10320 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.32e-04 | 44 | 32 | 3 | M45014 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.40e-04 | 118 | 32 | 4 | M27316 | |
| Pathway | REACTOME_DRUG_ADME | 1.45e-04 | 119 | 32 | 4 | MM15692 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 2.49e-04 | 137 | 32 | 4 | M48232 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 3.09e-04 | 145 | 32 | 4 | M45512 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 3.25e-04 | 12 | 32 | 2 | M39611 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 3.42e-04 | 149 | 32 | 4 | M27888 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 3.79e-04 | 153 | 32 | 4 | MM15844 | |
| Pathway | WP_RUBINSTEINTAYBI_SYNDROME_1 | 5.15e-04 | 15 | 32 | 2 | M48323 | |
| Pathway | WP_IRON_METABOLISM_DISORDERS | 6.65e-04 | 17 | 32 | 2 | M48053 | |
| Pathway | REACTOME_SUMOYLATION | 8.39e-04 | 189 | 32 | 4 | M27214 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 9.01e-04 | 1432 | 32 | 10 | M509 | |
| Pathway | REACTOME_METAL_ION_SLC_TRANSPORTERS | 9.25e-04 | 20 | 32 | 2 | MM15077 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 1.02e-03 | 21 | 32 | 2 | M39631 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 1.28e-03 | 95 | 32 | 3 | M48268 | |
| Pathway | REACTOME_METAL_ION_SLC_TRANSPORTERS | 1.34e-03 | 24 | 32 | 2 | M18795 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 1.34e-03 | 24 | 32 | 2 | M46445 | |
| Pathway | KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG | 1.45e-03 | 25 | 32 | 2 | M18312 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 1.47e-03 | 220 | 32 | 4 | M27794 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 1.69e-03 | 27 | 32 | 2 | M26943 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.95e-03 | 29 | 32 | 2 | M45015 | |
| Pathway | KEGG_CELL_CYCLE | 2.80e-03 | 125 | 32 | 3 | M7963 | |
| Pathway | PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY | 2.83e-03 | 35 | 32 | 2 | M127 | |
| Pubmed | 1.45e-11 | 6 | 36 | 4 | 32527940 | ||
| Pubmed | 1.45e-11 | 6 | 36 | 4 | 20297805 | ||
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 3.38e-11 | 7 | 36 | 4 | 8467709 | |
| Pubmed | 3.38e-11 | 7 | 36 | 4 | 8464825 | ||
| Pubmed | 3.38e-11 | 7 | 36 | 4 | 27514509 | ||
| Pubmed | 6.75e-11 | 8 | 36 | 4 | 17179145 | ||
| Pubmed | 6.75e-11 | 8 | 36 | 4 | 20610558 | ||
| Pubmed | 6.75e-11 | 8 | 36 | 4 | 18052087 | ||
| Pubmed | 1.21e-10 | 9 | 36 | 4 | 22511988 | ||
| Pubmed | 2.02e-10 | 10 | 36 | 4 | 23642732 | ||
| Pubmed | 2.02e-10 | 10 | 36 | 4 | 11465080 | ||
| Pubmed | 2.02e-10 | 10 | 36 | 4 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 2.02e-10 | 10 | 36 | 4 | 22558097 | |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 4.76e-10 | 12 | 36 | 4 | 20308471 | |
| Pubmed | 4.76e-10 | 12 | 36 | 4 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 4.76e-10 | 12 | 36 | 4 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 6.86e-10 | 13 | 36 | 4 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 6.86e-10 | 13 | 36 | 4 | 25246029 | |
| Pubmed | 9.60e-10 | 14 | 36 | 4 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 9.60e-10 | 14 | 36 | 4 | 10836148 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 9.60e-10 | 14 | 36 | 4 | 14672974 | |
| Pubmed | 9.60e-10 | 14 | 36 | 4 | 9295054 | ||
| Pubmed | 1.02e-09 | 3 | 36 | 3 | 29519853 | ||
| Pubmed | 1.02e-09 | 3 | 36 | 3 | 12847094 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 1.74e-09 | 16 | 36 | 4 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 2.28e-09 | 17 | 36 | 4 | 20639394 | |
| Pubmed | 2.93e-09 | 18 | 36 | 4 | 20056724 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 3.58e-09 | 57 | 36 | 5 | 21886157 | |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 3.70e-09 | 19 | 36 | 4 | 23281178 | |
| Pubmed | 4.07e-09 | 4 | 36 | 3 | 17558305 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 1.01e-08 | 24 | 36 | 4 | 24625756 | |
| Pubmed | 1.02e-08 | 5 | 36 | 3 | 20565459 | ||
| Pubmed | 1.02e-08 | 5 | 36 | 3 | 15057901 | ||
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 8.52e-08 | 9 | 36 | 3 | 20732626 | |
| Pubmed | 1.67e-07 | 11 | 36 | 3 | 18695635 | ||
| Pubmed | 6.65e-07 | 66 | 36 | 4 | 19898482 | ||
| Pubmed | Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD. | 1.04e-06 | 2 | 36 | 2 | 18326691 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 25788583 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 25547628 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 15365174 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 30060949 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 29883959 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 11901093 | ||
| Pubmed | Ferroxidase hephaestin's cell-autonomous role in the retinal pigment epithelium. | 1.04e-06 | 2 | 36 | 2 | 22342521 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 11677206 | ||
| Pubmed | The oral iron chelator deferiprone protects against iron overload-induced retinal degeneration. | 1.04e-06 | 2 | 36 | 2 | 21051716 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 22031623 | ||
| Pubmed | Cp/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone. | 1.04e-06 | 2 | 36 | 2 | 26303407 | |
| Pubmed | Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. | 1.04e-06 | 2 | 36 | 2 | 10497143 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 18568343 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 29355933 | ||
| Pubmed | Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes. | 1.04e-06 | 2 | 36 | 2 | 17603215 | |
| Pubmed | Hephaestin and ceruloplasmin facilitate iron metabolism in the mouse kidney. | 1.04e-06 | 2 | 36 | 2 | 27991585 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 15709193 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 12944498 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 9647757 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 17529886 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 20089735 | ||
| Pubmed | Common origin of the human synovial sarcoma associated SS18 and SS18L1 gene loci. | 1.04e-06 | 2 | 36 | 2 | 16484776 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 17065470 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 31263155 | ||
| Pubmed | 1.52e-06 | 190 | 36 | 5 | 24816252 | ||
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | 2.10e-06 | 203 | 36 | 5 | 16916647 | |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 2.54e-06 | 211 | 36 | 5 | 24097068 | |
| Pubmed | Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. | 3.12e-06 | 3 | 36 | 2 | 14716005 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 30182051 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 17000779 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 19364970 | ||
| Pubmed | Iron promotes oxidative cell death caused by bisretinoids of retina. | 3.12e-06 | 3 | 36 | 2 | 29686088 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 16636344 | ||
| Pubmed | Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. | 3.12e-06 | 3 | 36 | 2 | 20007669 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 23721685 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 19244109 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 26247833 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 17339869 | ||
| Pubmed | Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. | 3.12e-06 | 3 | 36 | 2 | 24453052 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 19225446 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 23789755 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 22266867 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 23640881 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 17406868 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 24988611 | ||
| Pubmed | Neither human hephaestin nor ceruloplasmin forms a stable complex with transferrin. | 3.12e-06 | 3 | 36 | 2 | 18022819 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 16926188 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 19996319 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 16397224 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 11435705 | ||
| Pubmed | Conditional knockout of hephaestin in the neural retina disrupts retinal iron homeostasis. | 3.12e-06 | 3 | 36 | 2 | 35271829 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 18946804 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 26164627 | ||
| Pubmed | CBP/p300 is a cell type-specific modulator of CLOCK/BMAL1-mediated transcription. | 6.24e-06 | 4 | 36 | 2 | 19922678 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 20147615 | ||
| Pubmed | Mice with hepcidin-resistant ferroportin accumulate iron in the retina. | 6.24e-06 | 4 | 36 | 2 | 26506980 | |
| Pubmed | Synergism between p68 RNA helicase and the transcriptional coactivators CBP and p300. | 6.24e-06 | 4 | 36 | 2 | 12527917 | |
| Pubmed | Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK:BMAL1. | 6.24e-06 | 4 | 36 | 2 | 16606840 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 20628391 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 9271343 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 23700788 | ||
| Pubmed | Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1. | 6.24e-06 | 4 | 36 | 2 | 2108603 | |
| Pubmed | Age-dependent retinal iron accumulation and degeneration in hepcidin knockout mice. | 6.24e-06 | 4 | 36 | 2 | 20811044 | |
| Interaction | UGT1A9 interactions | 1.48e-06 | 13 | 36 | 3 | int:UGT1A9 | |
| Interaction | UGT1A7 interactions | 3.17e-06 | 57 | 36 | 4 | int:UGT1A7 | |
| Interaction | UGT1A8 interactions | 9.30e-06 | 3 | 36 | 2 | int:UGT1A8 | |
| Interaction | UGT1A10 interactions | 2.75e-05 | 33 | 36 | 3 | int:UGT1A10 | |
| Interaction | ERG interactions | 4.52e-05 | 223 | 36 | 5 | int:ERG | |
| Interaction | TBXT interactions | 5.32e-05 | 116 | 36 | 4 | int:TBXT | |
| Interaction | PAX7 interactions | 6.91e-05 | 124 | 36 | 4 | int:PAX7 | |
| Interaction | CREBBP interactions | 7.80e-05 | 599 | 36 | 7 | int:CREBBP | |
| Cytoband | 2q37 | 9.87e-09 | 31 | 36 | 4 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 2.98e-05 | 226 | 36 | 4 | chr2q37 | |
| Cytoband | Xq25 | 4.81e-04 | 41 | 36 | 2 | Xq25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq25 | 6.59e-04 | 48 | 36 | 2 | chrXq25 | |
| GeneFamily | UDP glucuronosyltransferases | 9.96e-08 | 32 | 25 | 4 | 363 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.46e-04 | 17 | 25 | 2 | 486 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.10e-07 | 188 | 36 | 5 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.10e-07 | 188 | 36 | 5 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.10e-07 | 188 | 36 | 5 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|COVID-19_Convalescent / Disease condition and Cell class | 1.92e-05 | 198 | 36 | 4 | f65fd9b773aeafa55e38309479954a8e41371f52 | |
| Drug | naringenin chalcone | 2.63e-11 | 5 | 36 | 4 | ctd:C027329 | |
| Drug | anthrarobin | 2.63e-11 | 5 | 36 | 4 | ctd:C032186 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 7.88e-11 | 6 | 36 | 4 | ctd:C543211 | |
| Drug | alloin | 7.88e-11 | 6 | 36 | 4 | ctd:C006457 | |
| Drug | 3-phenylpropionic acid | 7.88e-11 | 6 | 36 | 4 | ctd:C035253 | |
| Drug | 2',5'-dihydroxychalcone | 7.88e-11 | 6 | 36 | 4 | ctd:C107497 | |
| Drug | almokalant | 8.47e-11 | 19 | 36 | 5 | CID003033962 | |
| Drug | 2',4'-dihydroxychalcone | 1.84e-10 | 7 | 36 | 4 | ctd:C059354 | |
| Drug | 1,4-dihydroxyanthraquinone | 3.67e-10 | 8 | 36 | 4 | ctd:C034890 | |
| Drug | 5-MOP | 3.84e-10 | 25 | 36 | 5 | CID000002355 | |
| Drug | AC1MRQNQ | 6.59e-10 | 9 | 36 | 4 | CID003522271 | |
| Drug | DHPASiU | 6.59e-10 | 9 | 36 | 4 | CID000197602 | |
| Drug | Chebi:32663 | 6.59e-10 | 9 | 36 | 4 | CID005460873 | |
| Drug | 3-iodophenol | 6.59e-10 | 9 | 36 | 4 | CID000012272 | |
| Drug | AC1L4J7U | 6.59e-10 | 9 | 36 | 4 | CID000186631 | |
| Drug | 2,6-dihydroxyanthraquinone | 1.10e-09 | 10 | 36 | 4 | ctd:C034889 | |
| Drug | PCB 156 | 1.22e-09 | 31 | 36 | 5 | CID000038019 | |
| Drug | indole-2-carboxylic acid | 1.44e-09 | 32 | 36 | 5 | CID000072899 | |
| Drug | geniposide | 1.70e-09 | 33 | 36 | 5 | CID000107848 | |
| Drug | 4-nitrophenyl)imidazole | 1.72e-09 | 11 | 36 | 4 | CID000123155 | |
| Drug | AC1O5XMV | 1.72e-09 | 11 | 36 | 4 | CID006442661 | |
| Drug | N-OH-DABZ | 2.58e-09 | 12 | 36 | 4 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 2.58e-09 | 12 | 36 | 4 | CID000088735 | |
| Drug | 4-hydroxyestrone | 2.58e-09 | 12 | 36 | 4 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 2.58e-09 | 12 | 36 | 4 | CID000037247 | |
| Drug | 7,7,7-triphenylheptanoic acid | 2.58e-09 | 12 | 36 | 4 | CID000276709 | |
| Drug | nonanoyl-N-methylglucamide | 2.58e-09 | 12 | 36 | 4 | CID000160090 | |
| Drug | 2-hydroxyestrone | 3.72e-09 | 13 | 36 | 4 | ctd:C024980 | |
| Drug | tritanol | 3.72e-09 | 13 | 36 | 4 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 3.72e-09 | 13 | 36 | 4 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 3.72e-09 | 13 | 36 | 4 | CID000000411 | |
| Drug | alizarin | 3.72e-09 | 13 | 36 | 4 | ctd:C010078 | |
| Drug | propranolol glucuronide | 5.21e-09 | 14 | 36 | 4 | CID000119515 | |
| Drug | PCB-61 | 5.21e-09 | 14 | 36 | 4 | CID000036401 | |
| Drug | PTBP | 6.03e-09 | 42 | 36 | 5 | CID000007393 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 7.09e-09 | 15 | 36 | 4 | CID000040469 | |
| Drug | coumarin-3-carboxylic acid | 7.09e-09 | 15 | 36 | 4 | CID000010752 | |
| Drug | bergamottin | 7.09e-09 | 15 | 36 | 4 | ctd:C068337 | |
| Drug | sulforaphane nitrile | 7.09e-09 | 15 | 36 | 4 | CID000543743 | |
| Drug | afloqualone | 7.09e-09 | 15 | 36 | 4 | CID000002040 | |
| Drug | naphthyl sulphate | 7.09e-09 | 15 | 36 | 4 | CID000114775 | |
| Drug | quercetin-3,4'-diglucoside | 9.45e-09 | 16 | 36 | 4 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 9.45e-09 | 16 | 36 | 4 | CID000040003 | |
| Drug | bilirubin-phosphate | 9.45e-09 | 16 | 36 | 4 | CID005497144 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 1.23e-08 | 17 | 36 | 4 | CID000003573 | |
| Drug | 6-hydroxychrysene | 1.23e-08 | 17 | 36 | 4 | CID000037766 | |
| Drug | EM-652 | 1.34e-08 | 49 | 36 | 5 | CID000155435 | |
| Drug | 2-vanillin | 1.45e-08 | 4 | 36 | 3 | ctd:C060843 | |
| Drug | hydratropic acid | 1.45e-08 | 4 | 36 | 3 | ctd:C013025 | |
| Drug | diphenylacetic acid | 1.45e-08 | 4 | 36 | 3 | ctd:C037760 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 1.59e-08 | 18 | 36 | 4 | CID000152226 | |
| Drug | Br 2 | 1.59e-08 | 18 | 36 | 4 | CID003060900 | |
| Drug | SureCN12722713 | 1.59e-08 | 18 | 36 | 4 | CID005488034 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 1.59e-08 | 18 | 36 | 4 | CID000036614 | |
| Drug | ApApG | 1.59e-08 | 18 | 36 | 4 | CID003081975 | |
| Drug | C1 11-32 | 1.59e-08 | 18 | 36 | 4 | CID000443077 | |
| Drug | C11131 | 1.59e-08 | 18 | 36 | 4 | CID000443076 | |
| Drug | 9-OH-risperidone | 2.01e-08 | 19 | 36 | 4 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 2.01e-08 | 19 | 36 | 4 | CID000091433 | |
| Drug | tectochrysin | 2.50e-08 | 20 | 36 | 4 | CID005281954 | |
| Drug | AC1L1OBF | 2.50e-08 | 20 | 36 | 4 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 2.50e-08 | 20 | 36 | 4 | CID000116545 | |
| Drug | entacapone | 2.50e-08 | 20 | 36 | 4 | ctd:C071192 | |
| Drug | Invader | 2.67e-08 | 56 | 36 | 5 | CID006442259 | |
| Drug | estriol-16-glucuronide | 3.09e-08 | 21 | 36 | 4 | CID000122281 | |
| Drug | dulcin | 3.09e-08 | 21 | 36 | 4 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 3.09e-08 | 21 | 36 | 4 | CID000069186 | |
| Drug | morin | 3.19e-08 | 58 | 36 | 5 | ctd:C008548 | |
| Drug | isovaleric acid | 3.62e-08 | 5 | 36 | 3 | ctd:C008216 | |
| Drug | biphenylylacetic acid | 3.62e-08 | 5 | 36 | 3 | ctd:C012776 | |
| Drug | amonafide | 3.77e-08 | 22 | 36 | 4 | CID000050515 | |
| Drug | plumbagin | 3.77e-08 | 22 | 36 | 4 | ctd:C014758 | |
| Drug | N-methylpiperazine | 3.77e-08 | 22 | 36 | 4 | CID000053167 | |
| Drug | amidoxime | 4.56e-08 | 23 | 36 | 4 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 4.56e-08 | 23 | 36 | 4 | CID000066651 | |
| Drug | phenanthridine | 4.56e-08 | 23 | 36 | 4 | CID000009189 | |
| Drug | 2-hydroxyestradiol | 4.87e-08 | 63 | 36 | 5 | CID000009684 | |
| Drug | cinnamic acid | 5.47e-08 | 24 | 36 | 4 | ctd:C029010 | |
| Drug | AS-3201 | 5.47e-08 | 24 | 36 | 4 | CID000153948 | |
| Drug | ethoxytriethyleneglycol | 6.17e-08 | 66 | 36 | 5 | CID000008190 | |
| Drug | Hymecromone | 6.50e-08 | 25 | 36 | 4 | ctd:D006923 | |
| Drug | AzMC | 6.50e-08 | 25 | 36 | 4 | CID000064986 | |
| Drug | N-acetylbenzidine | 6.50e-08 | 25 | 36 | 4 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 6.50e-08 | 25 | 36 | 4 | CID000006796 | |
| Drug | N-phenylmaleimide | 6.50e-08 | 25 | 36 | 4 | CID000013662 | |
| Drug | galangin | 7.18e-08 | 68 | 36 | 5 | ctd:C037032 | |
| Drug | Indoprofen | 7.24e-08 | 6 | 36 | 3 | ctd:D007216 | |
| Drug | Thymol | 7.67e-08 | 26 | 36 | 4 | ctd:D013943 | |
| Drug | Scopoletin | 9.00e-08 | 27 | 36 | 4 | ctd:D012603 | |
| Drug | DiMeIQx | 9.00e-08 | 27 | 36 | 4 | CID000104739 | |
| Drug | licochalcone A | 9.00e-08 | 27 | 36 | 4 | ctd:C070840 | |
| Drug | diflunisal | 9.00e-08 | 27 | 36 | 4 | CID000003059 | |
| Drug | N-hydroxy-4-aminobiphenyl | 1.05e-07 | 28 | 36 | 4 | CID000081261 | |
| Drug | CARMINE | 1.05e-07 | 28 | 36 | 4 | CID000014749 | |
| Drug | erucin | 1.05e-07 | 28 | 36 | 4 | CID000078160 | |
| Drug | H-Ni | 1.05e-07 | 28 | 36 | 4 | CID000445665 | |
| Drug | AC1L1JAL | 1.22e-07 | 29 | 36 | 4 | CID000004954 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 1.22e-07 | 29 | 36 | 4 | CID005375667 | |
| Drug | trans-3'-hydroxycotinine | 1.22e-07 | 29 | 36 | 4 | CID000000414 | |
| Drug | 7-hydroxycoumarin glucuronide | 1.22e-07 | 29 | 36 | 4 | CID000125641 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 9.32e-12 | 5 | 36 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 9.32e-12 | 5 | 36 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 9.32e-12 | 5 | 36 | 4 | EFO_0801853 | |
| Disease | X-21339 measurement | 6.51e-11 | 7 | 36 | 4 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 1.30e-10 | 8 | 36 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 1.30e-10 | 8 | 36 | 4 | EFO_0022118 | |
| Disease | X-11530 measurement | 1.30e-10 | 8 | 36 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 1.30e-10 | 8 | 36 | 4 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 1.30e-10 | 8 | 36 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 1.30e-10 | 8 | 36 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 1.30e-10 | 8 | 36 | 4 | EFO_0800692 | |
| Disease | X-24849 measurement | 1.30e-10 | 8 | 36 | 4 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 1.30e-10 | 8 | 36 | 4 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 1.30e-10 | 8 | 36 | 4 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 1.30e-10 | 8 | 36 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 1.30e-10 | 8 | 36 | 4 | EFO_0800766 | |
| Disease | X-11442 measurement | 2.34e-10 | 9 | 36 | 4 | EFO_0021236 | |
| Disease | X-11441 measurement | 2.34e-10 | 9 | 36 | 4 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 2.34e-10 | 9 | 36 | 4 | EFO_0004739 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 2.34e-10 | 9 | 36 | 4 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 2.34e-10 | 9 | 36 | 4 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 2.34e-10 | 9 | 36 | 4 | EFO_0801036 | |
| Disease | X-11880 measurement | 2.34e-10 | 9 | 36 | 4 | EFO_0800698 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 2.34e-10 | 9 | 36 | 4 | EFO_0004570, GO_0009410 | |
| Disease | protein-tyrosine kinase 6 measurement | 2.34e-10 | 9 | 36 | 4 | EFO_0020691 | |
| Disease | X-21448 measurement | 3.90e-10 | 10 | 36 | 4 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 3.90e-10 | 10 | 36 | 4 | EFO_0802185 | |
| Disease | X-23974 measurement | 3.90e-10 | 10 | 36 | 4 | EFO_0800867 | |
| Disease | bilirubin measurement, response to tenofovir | 3.90e-10 | 10 | 36 | 4 | EFO_0004570, EFO_0009279 | |
| Disease | X-21796 measurement | 6.12e-10 | 11 | 36 | 4 | EFO_0800825 | |
| Disease | pregnenetriol sulfate measurement | 6.12e-10 | 11 | 36 | 4 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 6.12e-10 | 11 | 36 | 4 | EFO_0600039 | |
| Disease | insomnia, bilirubin measurement | 6.12e-10 | 11 | 36 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | histidine betaine (hercynine) measurement | 6.12e-10 | 11 | 36 | 4 | EFO_0800972 | |
| Disease | aldosterone measurement | 6.12e-10 | 11 | 36 | 4 | EFO_0010219 | |
| Disease | biliverdin measurement | 9.17e-10 | 12 | 36 | 4 | EFO_0021033 | |
| Disease | p-cresol glucuronide measurement | 9.17e-10 | 12 | 36 | 4 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 1.32e-09 | 13 | 36 | 4 | EFO_0802007 | |
| Disease | pregnenetriol disulfate measurement | 1.32e-09 | 13 | 36 | 4 | EFO_0800587 | |
| Disease | blood 4-oxo-retinoic acid measurement | 1.67e-09 | 3 | 36 | 3 | EFO_0022216 | |
| Disease | indole-3-carboxylate measurement | 1.67e-09 | 3 | 36 | 3 | EFO_0800043 | |
| Disease | X-21441 measurement | 4.39e-09 | 17 | 36 | 4 | EFO_0800814 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 4.39e-09 | 17 | 36 | 4 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 5.64e-09 | 18 | 36 | 4 | EFO_0801382 | |
| Disease | tissue factor measurement | 1.10e-08 | 21 | 36 | 4 | EFO_0010623 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 3.33e-08 | 6 | 36 | 3 | EFO_0800566 | |
| Disease | neuroblastoma, cutaneous melanoma | 3.74e-08 | 28 | 36 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | xanthurenate measurement | 4.34e-08 | 29 | 36 | 4 | EFO_0010551 | |
| Disease | response to dolutegravir | 5.00e-08 | 30 | 36 | 4 | EFO_0600017 | |
| Disease | cholelithiasis | 7.37e-08 | 88 | 36 | 5 | EFO_0004799 | |
| Disease | vitamin D deficiency | 1.20e-07 | 37 | 36 | 4 | EFO_0003762 | |
| Disease | indoleacetate measurement | 1.99e-07 | 10 | 36 | 3 | EFO_0021015 | |
| Disease | gallstones | 2.06e-07 | 108 | 36 | 5 | EFO_0004210 | |
| Disease | vitamin D measurement, COVID-19 | 3.80e-07 | 49 | 36 | 4 | EFO_0004631, MONDO_0100096 | |
| Disease | X-24588 measurement | 4.73e-07 | 13 | 36 | 3 | EFO_0800898 | |
| Disease | urate measurement, spine bone mineral density | 7.55e-07 | 58 | 36 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | thyroxine measurement | 3.20e-06 | 83 | 36 | 4 | EFO_0005130 | |
| Disease | hormone measurement | 3.36e-06 | 84 | 36 | 4 | EFO_0004730 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 3.08e-05 | 147 | 36 | 4 | DOID:9352 (biomarker_via_orthology) | |
| Disease | AMYOTROPHIC LATERAL SCLEROSIS 1 | 3.14e-05 | 50 | 36 | 3 | C1862939 | |
| Disease | free androgen index | 8.69e-05 | 374 | 36 | 5 | EFO_0007005 | |
| Disease | dodecanedioate measurement | 9.48e-05 | 12 | 36 | 2 | EFO_0021054 | |
| Disease | urate measurement, bone density | 9.48e-05 | 619 | 36 | 6 | EFO_0003923, EFO_0004531 | |
| Disease | serum gamma-glutamyl transferase measurement | 1.02e-04 | 914 | 36 | 7 | EFO_0004532 | |
| Disease | melanoma | 2.32e-04 | 248 | 36 | 4 | C0025202 | |
| Disease | diabetes mellitus (implicated_via_orthology) | 4.62e-04 | 26 | 36 | 2 | DOID:9351 (implicated_via_orthology) | |
| Disease | Pigmented Basal Cell Carcinoma | 5.36e-04 | 28 | 36 | 2 | C1368275 | |
| Disease | metabolite measurement | 5.61e-04 | 560 | 36 | 5 | EFO_0004725 | |
| Disease | Carcinoma, Basal Cell | 5.76e-04 | 29 | 36 | 2 | C4721806 | |
| Disease | Schizophrenia | 6.38e-04 | 883 | 36 | 6 | C0036341 | |
| Disease | vitamin D measurement | 7.30e-04 | 336 | 36 | 4 | EFO_0004631 | |
| Disease | testosterone measurement | 7.68e-04 | 1275 | 36 | 7 | EFO_0004908 | |
| Disease | Carcinoma, Transitional Cell | 1.15e-03 | 41 | 36 | 2 | C0007138 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MAGGMAGHGQFQQPQ | 2221 | Q92793 | |
| GDFSMQQHGQPQQRM | 196 | Q9P2D1 | |
| NPMMTNGVVHANVFG | 11 | Q9UJX4 | |
| INGRMFGNLQGLTMH | 961 | P00450 | |
| GHFIASGMVNQEMLN | 21 | Q9NVX0 | |
| GMQNGTGQTDFMIHQ | 346 | O95835 | |
| SQSKHGMNGFFQQQM | 226 | Q13480 | |
| HQRMTNGAMNVEIGN | 4456 | Q07954 | |
| QYGSNVPNMHNGMNQ | 576 | P17844 | |
| MHGGANITGFQIVNN | 261 | P42263 | |
| QQSQGMLGQSSVHQM | 1916 | Q93074 | |
| QGNGLFQQGNEMMSL | 1041 | O94916 | |
| MHQDGISSMNQLGGL | 1 | O43316 | |
| AQSNTIQGGMIGNFM | 136 | Q5SVS4 | |
| IQGGMIGNFMNIYQQ | 141 | Q5SVS4 | |
| VQGQNLDSMLHGTGM | 21 | P36894 | |
| MGHEQNQGAALLQML | 1 | P28067 | |
| HNAAFMQIPMGLEGN | 196 | Q96RP9 | |
| HGEQGQMPENMQVSQ | 56 | O00482 | |
| PALQQTMQAMLHFGG | 686 | Q9BVN2 | |
| QGCMNNVTLGNAHMG | 1101 | O14841 | |
| HGVMFQGNTVQLQGM | 656 | Q9BQS7 | |
| VMGTQMNVIGQSAFG | 881 | Q6P3W7 | |
| MNVIGQSAFGMQGNP | 886 | Q6P3W7 | |
| IQEQLQMVHGQGLQM | 551 | O15516 | |
| QMVHGQGLQMFLQQS | 556 | O15516 | |
| MNTGHIGTTQHMIQQ | 611 | O15516 | |
| VVMVGLGDHQFQMQL | 891 | Q86XI2 | |
| PRNMMNHSQVGQGIG | 136 | Q9NZN8 | |
| QHYQGQSSIAMMGQG | 206 | O75177 | |
| HDPVMGSQANYGMQQ | 1086 | Q9C0B9 | |
| GTGNQMLQVMENGRF | 3056 | Q96RL7 | |
| MPNMIFIGGINCHQG | 266 | Q9HAW8 | |
| NGHHQQNGVENMMLF | 71 | Q8N3U4 | |
| AQQQITSGQMHRGHM | 471 | Q9Y490 | |
| GQVNQGNHMMGQRQI | 236 | Q15532 | |
| LHIYMNGTMSQVQGS | 366 | P14679 | |
| MPNMIFIGGINCHQG | 266 | O60656 | |
| MPNMIFIGGINCHQG | 266 | Q9HAW7 | |
| MPNMIFIGGINCHQG | 266 | Q9HAW9 |